HDAC6 and amyotrophic lateral sclerosis: These results are consistent with our finding that, among the sense DPR proteins, HDAC6 specifically interacts with poly (GA), and suggest that HDAC6 represents a novel therapeutic target to alleviate poly (GA) pathology in c9FTD/ALS.